Goldman Sachs’s SOLAZYME INC COM STK (DE) SZYM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q2 | – | Sell |
-794,380
| Closed | -$1.61M | – | 7493 |
|
|
2016
Q1 | $1.61M | Buy |
794,380
+544,729
| +218% | +$972K | ﹤0.01% | 3672 |
|
|
2015
Q4 | $619K | Sell |
249,651
-173,850
| -41% | -$516K | ﹤0.01% | 4733 |
|
|
2015
Q3 | $1.1M | Buy |
423,501
+18,135
| +4% | +$47.3K | ﹤0.01% | 4380 |
|
|
2015
Q2 | $1.27M | Sell |
405,366
-471,188
| -54% | -$1.61M | ﹤0.01% | 4303 |
|
|
2015
Q1 | $2.51M | Sell |
876,554
-189,904
| -18% | -$485K | ﹤0.01% | 3560 |
|
|
2014
Q4 | $2.75M | Buy |
1,066,458
+1,042,344
| +4,323% | +$4.56M | ﹤0.01% | 3535 |
|
|
2014
Q3 | $180K | Sell |
24,114
-958
| -4% | -$8.95K | ﹤0.01% | 6241 |
|
|
2014
Q2 | $295K | Sell |
25,072
-183,636
| -88% | -$1.96M | ﹤0.01% | 5855 |
|
|
2014
Q1 | $2.42M | Buy |
208,708
+190,161
| +1,025% | +$2.24M | ﹤0.01% | 3794 |
|
|
2013
Q4 | $202K | Sell |
18,547
-326,758
| -95% | -$3.22M | ﹤0.01% | 5958 |
|
|
2013
Q3 | $3.72M | Buy |
345,305
+229,518
| +198% | +$2.61M | ﹤0.01% | 3262 |
|
|
2013
Q2 | $1.36M | Buy |
+115,787
| New | +$1.16M | ﹤0.01% | 4117 |
|
Goldman Sachs's SZYM Position: Q2 2016 in Review
Goldman Sachs sold out of SOLAZYME INC COM STK (DE) (SZYM) in Q2 2016, closing a stake of 794,380 shares — an estimated $1.61M sold.
Goldman Sachs first reported a position in SZYM in Q2 2013 and held it in 12 quarters. The position peaked at $3.72M in Q3 2013. 0 funds tracked by Wall St. Rank hold SZYM as of Q2 2016.
- Goldman Sachs reported no remaining SOLAZYME INC COM STK (DE) position as of Q2 2016 after selling out during the quarter.
- Goldman Sachs sold 794,380 SOLAZYME INC COM STK (DE) shares in Q2 2016, an estimated $1.61M.
- Goldman Sachs first reported a position in SOLAZYME INC COM STK (DE) in Q2 2013 and held it in 12 quarters.
- Goldman Sachs's SOLAZYME INC COM STK (DE) position peaked at $3.72M in Q3 2013.
- 0 funds tracked by Wall St. Rank held SOLAZYME INC COM STK (DE) as of Q2 2016.
Based on Goldman Sachs's 13F filing for Q2 2016, filed 15 Aug 2016.